• Study: Gene therapy improves Parkinson's patients' motor function (Reuters), http://ow.ly/4h467 #
  • Bluebird bio forms potential $4.2M deal with French Muscular Dystrophy Association (Mass High Tech Business News), http://ow.ly/4h483 #
  • Apple's component deals should help it weather Japan crisis (CNET News), http://ow.ly/4h4iF #
  • Blog site provides new marketing outlet for TTOs (IP Marketing Advisor), http://ow.ly/4h4sa #techtransfer #
  • Montreal: A humorous guide (Cracked), http://ow.ly/4h4Cg #
  • Tekmira Sues Alnylam for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets (Xconomy), http://ow.ly/4h47d #
  • Open & Honest: Don't be afraid to show your warts to investors (StartupCFO : Mark MacLeod), http://ow.ly/4gxR7 #
  • U.S. watches as other governments fund stem cell research (Nature News), http://ow.ly/4ghC2 #
  • Institute for Systems Biology co-founder to lead Seattle Biomed (Seattle Times Newspaper), http://ow.ly/4ghCH #
  • U.K. and U. of Massachusetts stem cell banks enter collaboration (Mass High Tech Business News), http://ow.ly/4ghDv #
  • Cytovance to expand in Oklahoma City with $22.5M investment (News OK), http://ow.ly/4ghEc #
  • ImmusanT establishes office in Cambridge, Mass. (Boston Globe), http://ow.ly/4ghEE #
  • HGS acquires licensing rights to a cancer drug from FivePrime (Silicon Valley / San Jose Business Journal), http://ow.ly/4h44g #
  • Tax rules for Canadians abroad (Business – CBC News), http://ow.ly/4hi4N #
  • Are the Canadiens the NHL's most hated team? (The Globe and Mail) http://ow.ly/4hloG #

Comments are closed.